comparemela.com

Latest Breaking News On - Synerkine pharma - Page 1 : comparemela.com

NOTICE OF EXTRAORDINARY GENERAL MEETING IN MENDUS AB (PUBL)

Press Release Stockholm, Sweden, November 13, 2023 The shareholders of Mendus AB , reg. no 556629-1786, are hereby invited to the Extraordinary General Meeting on Wednesday, 13.

City ofUnited kingdomHans preustingChristine lindDharminder chahalAndrea van elsasErik mantingSynerkine pharmaSven andreassonArticles of associationEmployee stock option programSwedish companiesSwedish companies registration officeEuropean parliamentTekiu ltdCompany the participants

Dutch-based Synerkine Pharma scores €5 3M to create innovative pain solutions

Synerkine Pharma, a biopharmaceutical company based in Leiden has successfully secured €5.3M in an extension of its Series A financing.

City ofUnited kingdomSynerkine pharmaHans preustingUniversity medical center utrechtNetherlands enterprise agencyUtrecht health seed fundInnovationquarter capitalNetherlands enterpriseThuja capitalChief executive officerUniversity medical center

Synerkine Pharma Raises EUR 3 5 Million in an Extended Series A Financing

Synerkine Pharma Raises EUR 3.5 Million in an Extended Series A Financing - read this article along with other careers information, tips and advice on BioSpace

United kingdomCity ofNoord hollandSynerkine pharmaHans preustingThomas elderedUniversity medical center utrechtUtrecht holdingsBritish venture capital associationFlerie investThuja capitalYnerkine pharma raises eur 3 5 million in an extended seriesa financing

vimarsana © 2020. All Rights Reserved.